Cargando…

Sofosbuvir for COVID-19 infection: A potential candidate

Detalles Bibliográficos
Autores principales:	Gupta, Rohit, Dhamija, Puneet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446683/ https://www.ncbi.nlm.nih.gov/pubmed/32874010 http://dx.doi.org/10.4103/ijp.IJP_675_20

Ejemplares similares

Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis
por: Chan, Huan-Tee, et al.
Publicado: (2021)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

The Efficacy and Safety of Sofosbuvir/Ledipasvir Therapy in Patients on Long-term Hemodialysis with Hepatitis C Virus Infection
por: Cavoli, G. Li, et al.
Publicado: (2018)

Fixed drug eruption – Experience from a tertiary care center in Uttarakhand
por: Hazarika, Neirita, et al.
Publicado: (2023)

Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
por: Rey, Esther, et al.
Publicado: (2021)

Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
por: Thalhammer, Julian, et al.
Publicado: (2021)

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir
por: Katiyar, Harshita, et al.
Publicado: (2023)

Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
por: Kayarat, Bhavana, et al.
Publicado: (2021)

Blood donor deferral periods after COVID-19 vaccination
por: Gupta, Abhaykumar Malind, et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis complicating nontuberculous mycobacterial infection
por: Gupta, Stuti, et al.
Publicado: (2019)

Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C
por: Lin, R J, et al.
Publicado: (2016)

Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
por: Arora, Rishi, et al.
Publicado: (2023)

Sofosbuvir as a potential option for the treatment of COVID-19
por: Nourian, Anahid, et al.
Publicado: (2020)

Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites
por: Qiu, Shizheng, et al.
Publicado: (2022)

Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment
por: Szymanek-Pasternak, Anna, et al.
Publicado: (2022)

Effects of COVID-19 lockdowns on PhD candidates
por: Hlongwa, Mbuzeleni
Publicado: (2020)

Ophthalmic surgery on a COVID-19 positive patient – First experience!
por: Jayadev, Chaitra, et al.
Publicado: (2021)

Ipsilesional Torsional Nystagmus in Midbrain Infarction: A Rare Entity of Localizing Value
por: Garg, Divyani, et al.
Publicado: (2020)

Eyes Have It: From COVID-19 Perspective
por: Sarkar, Soumya, et al.
Publicado: (2020)

COVID-19 and Cannabis: Playing Saint or Devil?
por: Garg, Heena, et al.
Publicado: (2021)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2022)

Young Male with Paraparesis and Vision Loss- A Rare Presentation of Eales' Disease
por: Chawla, Tanushree, et al.
Publicado: (2020)

Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
por: Seligmann, Hervé
Publicado: (2021)

In Pursuit of Freedom from COVID-19 Awareness in India: An Infodemiological Analysis
por: Sarkar, Soumya, et al.
Publicado: (2021)

Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance
por: Kayarat, Bhavana, et al.
Publicado: (2021)

COVID-19 Infection in CAPD Patients: A Single-Center Indian Experience
por: Parthasarathy, Rajeevalochana, et al.
Publicado: (2022)

Potential Association between Periodontitis and COVID-19 Infection Outcomes
por: Chowdhri, Kanika, et al.
Publicado: (2021)

Physical exercise: Potential candidate as complementary therapy for epilepsy
por: Arida, Ricardo Mario, et al.
Publicado: (2012)

The Efficacy and Safety of Sofosbuvir-Containing Regimen in the Treatment of HCV Infection in Patients with Haemoglobinopathy
por: Hussein, N.R.
Publicado: (2017)

A rare case of modafinil dependence presenting as sleep disorder
por: Samudra, Madhura, et al.
Publicado: (2021)

Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19
por: Zandi, Milad, et al.
Publicado: (2021)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
por: Oronsky, Bryan, et al.
Publicado: (2022)

Fatal cerebral infarct in a child with COVID-19
por: Kihira, Shingo, et al.
Publicado: (2020)

Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018)

Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection
por: Pathak, Subodh Kumar, et al.
Publicado: (2020)

Potential future implications of the COVID-19 pandemic on Norovirus infections in England
por: Hotham, M.
Publicado: (2021)

In search of acute surgical stress biomarkers: Is ghrelin a potential candidate?
por: Kontoravdis, Nikolaos, et al.
Publicado: (2013)

Paediatric ocular examination under anaesthesia during the COVID-19 pandemic: Child cannot wait
por: Shanmugam, Nirmal, et al.
Publicado: (2021)

Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients
por: Baltodano-Calle, Maria J., et al.
Publicado: (2022)

Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
por: Skayem, Charbel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_de5nev2d87gmu74g023u39edmh